Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × dacomitinib × 90 days × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Surveys and Questionnaires 46 Blood Specimen Collection 36 Specimen Handling 29 Observation 18 Radiotherapy 15 Interviews as Topic 15 Watchful Waiting 9 Immune Checkpoint Inhibitors 9 Magnetic Resonance Spectroscopy 8 Biopsy 8 Surgical Procedures, Operative 7 Data Collection 7 enzalutamide 6 Tissue Banks 6 Standard of Care 6 Drug Therapy 6 ribociclib 5 pembrolizumab 5 darolutamide 5 apalutamide 5 Tomography, X-Ray Computed 5 Therapeutics 5 Restraint, Physical 5 Magnetic Resonance Imaging 5 Liquid Biopsy 5 Focus Groups 5 lenvatinib 4 Nivolumab 4 Letrozole 4 Hematologic Tests 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04721106 2026-02-10

Korea Post Marketing Surveillance (PMS) Study of Vizimpro

Pfizer

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡